Mouwasat Medical Services Company (4002)

Saudi Arabia
Currency in SAR
88.10
-0.90(-1.01%)
Closed

Mouwasat (4002) Income Statement & Profits

Advanced Income Statement
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa1,857.212,045.032,144.142,334.112,705.51
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+10.74%+10.11%+4.85%+8.86%+15.91%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa1,037.571,096.451,162.681,249.331,410.82
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa819.64948.58981.461,084.781,294.69
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+7.11%+15.73%+3.47%+10.53%+19.35%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa44.13%46.38%45.77%46.48%47.85%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa349.15370.75359.53412.32538.12
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-3.33%+6.19%-3.03%+14.68%+30.51%
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa349.15370.75359.53419.05546.51
aa.aaaa.aaaa.aaaa.aaaa.aa----6.73-8.38
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa470.49577.84621.93672.46756.56
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+16.44%+22.82%+7.63%+8.12%+12.51%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa25.33%28.26%29.01%28.81%27.96%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-18.18-12.64-7.88-22.31-39.97
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-260.55%+30.47%+37.7%-183.16%-79.22%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-20.16-14.04-8.2-22.88-46.46
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa1.971.40.320.586.48
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa9.5111.2818.169.8810.21
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa461.82576.47632.21660.03726.79
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa0.410.4-0.020.240.29
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-----
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa462.23576.87632.2660.27727.09
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+13.1%+24.8%+9.59%+4.44%+10.12%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa24.89%28.21%29.48%28.29%26.87%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa13.4715.2421.7327.5838.7
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa448.76561.63610.46632.69688.39
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-27.73-33.47-32.3-33.38-30.7
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa421.03528.16578.16599.31657.69
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+16.89%+25.44%+9.47%+3.66%+9.74%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa22.67%25.83%26.96%25.68%24.31%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa421.03528.16578.16599.31657.69
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa2.112.642.8933.29
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+16.89%+25.44%+9.47%+3.66%+9.74%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa2.112.642.8933.29
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+16.89%+25.44%+9.47%+3.66%+9.74%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa200200200200200
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa200200200200200
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa11.251.381.51.75
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+14.29%+25%+10%+9.09%+16.67%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa610.31720.79773.9855.25974.55
EBITDA Growth
aa.aaaa.aa